Early removal of the etonogestrel contraceptive implant in Spanish women: a prospective cohort study

被引:0
|
作者
Ruiz de Vinaspre-Hernandez, Regina [1 ,2 ]
Garrido-Santamaria, Rosana [3 ]
Urra-Martinez, Raquel [3 ]
Saenz-Cabredo, Paula [4 ]
Garrido-Rivas, Ana Elena [1 ,2 ,4 ]
Juarez-Vela, Raul [1 ,2 ]
Sanchez-Gonzalez, Juan Luis [5 ]
Lafuente-Jimenez, Alberto [4 ]
Ramon-Arbues, Enrique [6 ,7 ]
Navas-Echazarreta, Noelia [1 ,2 ]
Santolalla-Arnedo, Ivan [1 ,2 ]
机构
[1] Univ La Rioja, Fac Hlth Sci, Logrono, Spain
[2] Univ La Rioja, Dept Nursing, Grupac Res Grp, Logrono, Spain
[3] Rioja Hlth Serv, Family Planning Ctr, Logrono, Spain
[4] Rioja Hlth Serv, Logrono, Spain
[5] Univ Salamanca, Dept Nursing & Physiotherapy, Salamanca, Spain
[6] San Jorge Univ, Fac Hlth Sci, Villanueva De Gallego, Spain
[7] Univ Zaragoza, SAPIENF Invest Grp, Zaragoza, Spain
关键词
etonogestrel; contraceptive; implant; early removal; cohort study; CHOICE PROJECT; CONTINUATION;
D O I
10.3389/fmed.2024.1172793
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose To know the discontinuation rate and characterize predictors and reasons of contraceptive implant removal within 12 months of insertion in our community setting.Methods This prospective cohort study included women receiving the etonogestrel contraceptive implant at sexual and reproductive health centers between September 2019 and September 2020. The variables collected were implanted insertion timing, reproductive and demographic characteristics, medical conditions, sexual activity and counseling. Our primary outcome was implant discontinuation. Kaplan-Meier survival curves were used to show the cumulative discontinuation rate of implants contraceptive within the first year of insertion. We also identified factors that increased the risk of implant removal using the log-rank test and the Cox regression model. Reasons for discontinuation were documented.Results 199 women were followed up. Implant discontinuation was documented in 17.1% of implant users prior to 12 months. Factors that increase the risk of implant removal are living with a partner, being aged 25-34 years and not receiving comprehensive and structured counseling from the midwife. The main reason for removal was unsatisfactory bleeding (97.1%), but this was combined with other reasons such as cessation of sexual intercourse (58.8%), worsening mood (58.8%), weight gain (55.9%) or decreased libido (50.0%).Conclusion The rate of discontinuous implant uses in the first year is relevant in relation to cost-effectiveness, there is room for improvement that should not be overlooked. Comprehensive and structured midwife-led counseling can reduce early implant abandonment removal. The development in different countries of the role of midwives in the management of contraceptives can contribute to the economic benefit of health services and the satisfaction of women.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Potential determinants of early discontinuation of Etonogestrel implant: a cohort prospective study
    Helmi, Zeena
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2024, 74 (10) : S105 - S110
  • [2] Pharmacokinetics of the etonogestrel contraceptive implant in obese women
    Mornar, Sara
    Chan, Lingtak-Neander
    Mistretta, Stephanie
    Neustadt, Amy
    Martins, Summer
    Gilliam, Melissa
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2012, 207 (02)
  • [3] PHARMACOKINETICS OF THE ETONOGESTREL CONTRACEPTIVE IMPLANT IN OBESE WOMEN
    Gilliam, M.
    Mornar, S.
    Chan, L. N.
    Mistretta, S.
    Kantor, E.
    Neustadt, A.
    CONTRACEPTION, 2011, 84 (03) : 305 - 306
  • [4] Early removal of etonogestrel subcutaneous contraceptive implant at a community health centre in Pretoria
    Moeti, Dikonketjo M. P.
    Govender, Indiran
    Bongongo, Tombo
    SOUTH AFRICAN FAMILY PRACTICE, 2022, 64 (01)
  • [5] Reasons for Early Removal of the Etonogestrel Subdermal Implant in Obese Women
    Hatch, Cherise
    Brouse, Brynne
    Young, Amanda
    Gray, Celia M.
    Paglia, Michael J.
    Howard, Denise
    OBSTETRICS AND GYNECOLOGY, 2022, 139 : 11S - 11S
  • [6] Gene expression associated with unfavorable vaginal bleeding in women using the etonogestrel subdermal contraceptive implant: a prospective study
    Torelli, Flavia R.
    Rodrigues-Peres, Raquel M.
    Monteiro, Ilza
    Lopes-Cendes, Iscia
    Bahamondes, Luis
    Juliato, Cassia R. T.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [7] Effect of cost on early removal of contraceptive implants: a prospective cohort study
    Lozano, Manuel
    Antonia Obiol, Maria
    Peiro, Juanjo
    Maria Ramada, Jose
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2019, 24 (01): : 24 - 29
  • [8] Prevalence of early discontinuation and associated factors among a retrospective cohort of etonogestrel contraceptive implant users
    Peterson, Andrea M.
    Brown, Amy
    Savage, Ashlyn
    Dempsey, Angela
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2019, 24 (06): : 475 - 479
  • [9] Effects of the etonogestrel contraceptive implant (Implanon®) on bone metabolism during lactation: a prospective study
    Duvan, Candan Iltemir
    Onaran, Yuksel
    Keskin, Esra Aktepe
    Yuce, Ebru
    Yanik, Burcu
    Kafali, Hasan
    Turhan, Nilgun Ozturk
    JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2017, 43 (02): : 113 - 117
  • [10] A prospective cohort study of early postpartum etonogestrel implant (Implanon®) use and its effect on duration of lochia
    Dobromilsky, Kim C.
    Allen, Penny L.
    Raymond, Stephen H.
    Maindiratta, Bhavna
    JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2016, 42 (03): : 187 - 193